Our co-hosts discuss who the NRG Protocol Operations Management "POM" Committee is and what they are responsible for with outgoing Chair, Dr. Maria Werner-Wasik and incoming Chair, Dr. Alexandra Thomas.

In the first half of this episode, our co-hosts interview NRG Oncology Sarcoma Subcommittee Chairs, Dr. Dian Wang and Dr. William Tseng on the priorities and goals of the newer subcommittee within NRG's organization.

In the second half, our co-hosts meet with MLB Player Chris Taylor and his wife Mary Taylor, the co-founders of the CT3 Foundation to discuss how sarcoma has touched their lives and fueled their passion to move the needle in sarcoma research.

This episode features our first ever guest co-host and former NRG Oncology Group Chair, Dr. Wally Curran.

JAMA Editor in Cheif, Dr. Kirsten Bibbins-Domingo discusses JAMA and the JAMA Network and the process for selection and publication of manuscripts.

We take a look at the barriers faced by smaller institutions and rural institutions with Dr. Naoto Ueno of the University of Hawaii in a two-episode series on small vs. larger institution challenges.

Today for Veteran's Day, we discuss the NRG Veteran Affairs and Military Treatment Facility Subcommittee and NCTN trials in the VA system with Subcommittee Chair, Dr. Vlad Sandulache.

For Pancreatic Cancer Awareness Month, we discuss the recently activated NRG-GI011 "LAP100" study for locally advanced pancreas cancer with study PI, Dr. Sanford.

Drs. Chun and Henke interview NRG NCORP PI, Dr. Deborah Bruner on the ins-and-outs of the NCI National Community Oncology Research Program (NCORP) as well as her trailblazing career thus far.

This episode, our co-hosts discuss the ASTRO late-breaking abstracts that were reported at the ASTRO 2025 annual meeting. Dr. Movsas discusses the quality of life results of NRG-LU005 and Dr. Mehta discusses the proton arm of NRG-BN001. Dr. Steven Frank takes a deeper look at proton implications through the NRG results that were presented at ASTRO.

PLEASE NOTE: There is a correction to Dr. Movsas’ institution as mentioned in the podcast in error. Dr. Movsas’ institution is Henry Ford Health.

NRG Oncology Podcast co-hosts sit with ASTRO President, Dr. Sameer Keole as well as ASTRO Plenary NRG research presenters, Dr. Shannon MacDonald (RadComp) and Dr. Rodney Ellis (NRG-GU005) to discuss results that were reported.

Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.